AMH: Don’t put all the eggs in one basket
Antimüllerian hormone (AMH), produced by preantral and early antral follicles of the ovary, serves as a quantitative measure of ovarian reserve and has changed the landscape of IVF practice. A commercial test for AMH has been available for more than 15 years and has become a standard part of female infertility assessment over the past decade. With a single blood test, clinicians can use AMH to roughly predict clinical response to controlled ovarian hyperstimulation and make treatment decisions accordingly (1).
Source: fertstert.org
AMH: Don’t put all the eggs in one basket
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment